1-3 of 3
Elizabeth Roman, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimal Ex-Vivo Expansion (EvE) of Cord Blood (CB) Natural Killer (NK) Cells, NK Cytotoxicity and NK Receptor (NKR) Expression: Potential for CB Adoptive Cellular Immunotherapy (ACI).

Janet Ayello, Prakash Satwani, MD, Carmella Van de Ven, Elizabeth Roman, MD, Laxmi Baxi, MD, Joanne Kurtzburg, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2005) 106 (11): 34.
https://doi.org/10.1182/blood.V106.11.34.34
Published: 2005
Journal Articles

Preliminary Results of Reduced Intensity Allogeneic Stem Cell Transplantation (RI ALLOSCT) followed by a Dose Escalation of Targeted Consolidative Immunotherapy with Gemtuzumab Ozogamicin (GO) in Pediatric Recipients with CD33+ AML.

Elizabeth Roman, MD, Lauren Harrison, RN, Erin Cooney, CPNP, Olga Militano, Pharm, Karen Wolownik, MSN, CPNP, Ria Hawks, MSN, CPNP, Mary Brigid Bradley, MD, Gustavo Del Toro, MD, Diane George, MD, James Garvin, MD, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2004) 104 (11): 4510.
https://doi.org/10.1182/blood.V104.11.4510.4510
Published: 2004
Journal Articles

Prolonged Ex Vivo Expansion (7–10 Days) of Cord Blood (CB) Recryopreserved and Rethawed Aliquots with Anti-CD3, IL-2, IL-12 Significantly Expands NKT Cells, NKT KIR Substes and NK Cytotoxicity Compared to Short-Term Expansion: Potential for CB Adoptive Cellular Immunotherapy (ACI).

Janet Ayello, MS, Prakash Satwani, MD, Carmella van de Ven, MA, Elizabeth Roman, MD, Allison O’Neill, Max Shutran, Matthew Greenhawt, MD, Laxmi Baxi, MD, Lynn Simpson, MD, Joanne Kurtzberg, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2004) 104 (11): 2845.
https://doi.org/10.1182/blood.V104.11.2845.2845
Published: 2004